웰팜

비상장계속사업자

Wellfarm Co., Ltd.

이서영

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

웰팜

Business Reg. No. 3038132171 · CEO 이서영

I.Investment Overview

Target웰팜 (3038132171)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명웰팜
영문명Wellfarm Co., Ltd.
대표자이서영
사업자등록번호3038132171
법인등록번호1545110022303
설립일2002.02.07

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW348.82021367.32022398.32023463.42024487.62025
영업이익100M KRW13.8202112.1202213.5202320.9202415.82025
순이익100M KRW7.620213.520226.220236.620245.72025
Item20252024202320222021
자산총계258.1억원274.9억원227억원213.3억원186.3억원
부채총계179.9억원200.7억원156.6억원147.9억원123.4억원
자본총계78.2억원74.2억원70.3억원65.4억원62.9억원
매출액487.6억원463.4억원398.3억원367.3억원348.8억원
영업이익15.8억원20.9억원13.5억원12.1억원13.8억원
순이익5.7억원6.6억원6.2억원3.5억원7.6억원

VI.Financial Ratios

FY2025 basis

3.25%

영업이익률

1.16%

순이익률

2.2%

ROA

7.26%

ROE

230.04%

부채비율

30.3%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

웰팜 투심보고서 | Alpha Lenz